Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
CALL
Targa Resources
TRGP
$55.1B
| $586K | ﹤0.01% |
29,200
-62,100
| -68% | -$934K |
|
3177
Banco Santander
SAN
$210B
| $585K | ﹤0.01% |
253,233
-188,672
| -43% | -$413K |
|
|
APLT
3178
DELISTED
Applied Therapeutics
APLT
| $584K | ﹤0.01% |
16,123
-8,650
| -35% | -$362K |
|
|
LNW
3179
DELISTED
Light & Wonder
LNW
| $584K | ﹤0.01% |
37,777
-24,197
| -39% | -$316K |
|
3180
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $584K | ﹤0.01% |
1,800
-8,900
| -83% | -$2.7M |
|
3181
Douglas Dynamics
PLOW
$1.02B
| $584K | ﹤0.01% |
16,632
+5,464
| +49% | +$189K |
|
3182
Universal Electronics
UEIC
$61.3M
| $584K | ﹤0.01% |
12,475
+1,124
| +10% | +$47.3K |
|
|
ZYXI
3183
DELISTED
Zynex
ZYXI
| $582K | ﹤0.01% |
25,706
+16,761
| +187% | +$281K |
|
|
COUP
3184
PUT
DELISTED
Coupa Software Incorporated
COUP
| $582K | ﹤0.01% |
2,100
-17,900
| -90% | -$3.61M |
|
3185
Cenovus Energy
CVE
$52.1B
| $581K | ﹤0.01% |
124,422
+109,195
| +717% | +$420K |
|
3186
uniQure
QURE
$3.22B
| $581K | ﹤0.01% |
+12,886
| New | +$761K |
|
3187
PUT
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.17B
| $581K | ﹤0.01% |
1,430
-1,460
| -51% | -$607K |
|
3188
Designer Brands
DBI
$333M
| $580K | ﹤0.01% |
85,823
-54,604
| -39% | -$330K |
|
3189
PUT
Boston Scientific
BSX
$71.5B
| $579K | ﹤0.01% |
16,500
-194,500
| -92% | -$7M |
|
3190
Oceaneering
OII
$4.77B
| $579K | ﹤0.01% |
90,701
+8,759
| +11% | +$46.2K |
|
|
GTHX
3191
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $579K | ﹤0.01% |
23,904
+19,142
| +402% | +$317K |
|
3192
CALL
Ball Corp
BALL
$16.8B
| $577K | ﹤0.01% |
8,300
-47,600
| -85% | -$3.22M |
|
3193
V2X
VVX
$2.65B
| $577K | ﹤0.01% |
11,728
-6,190
| -35% | -$299K |
|
|
RRD
3194
DELISTED
RR Donnelley & Sons Co.
RRD
| $577K | ﹤0.01% |
484,109
+425,486
| +726% | +$518K |
|
|
NWLI
3195
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $576K | ﹤0.01% |
2,838
+1,335
| +89% | +$254K |
|
|
TMX
3196
DELISTED
Terminix Global Holdings, Inc.
TMX
| $576K | ﹤0.01% |
16,159
-78,201
| -83% | -$2.41M |
|
3197
CALL
iShares US Real Estate ETF
IYR
$4.65B
| $575K | ﹤0.01% |
7,300
-142,600
| -95% | -$10.8M |
|
3198
EverQuote
EVER
$906M
| $574K | ﹤0.01% |
9,865
+2,041
| +26% | +$95.9K |
|
3199
PUT
ON Semiconductor
ON
$31.6B
| $571K | ﹤0.01% |
28,800
-21,800
| -43% | -$355K |
|
3200
PUT
Brunswick
BC
$5.28B
| $570K | ﹤0.01% |
8,900
-3,000
| -25% | -$150K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.